Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crolibulin plus Cisplatin in Solid Tumors and Anaplastic Thyroid Cancer
NCT01240590Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2011
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Crolibulin in anaplastic thyroid cancer (ATC), solid tumor, sponsored by National Cancer Institute. Started Jan 2011; status: completed.
02
Drugs
Crolibulin
03
Conditions
anaplastic thyroid cancer (ATC)solid tumor
Beyond the preview
Go deeper on NCT01240590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01240590.